Proteasome Inhibitors in Cancer Therapy By Julian Adams

Proteasome Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) by Julian Adams
Immediately upon the discovery some ten years ago that inhibition of the proteasome in cultured cells, mostly of tumor origin, caused the programmed cell death machinery to ramp up, it became imperative to investigate proteasome inhibition as a possible treatment for human cancers. In Proteasome Inhibitors in Cancer Therapy, Julian Adams, the leader in developing the field, brings together a panel of highly experienced academic and pharmaceutical investigators to take stock of the remarkable work that has been accomplished to date, and examine emerging therapeutic possibilities for proteasome inhibitors in cancer. 


Download
Link 1
or
Link 2